Platelet Aggregation Inhibitors


Indications and Reactions:

Role Indications Reactions
Secondary
Antiplatelet Therapy 72.7%
Ischaemic Stroke 13.6%
Drug Use For Unknown Indication 9.1%
Product Used For Unknown Indication 4.5%
Myocardial Infarction 16.7%
Aspiration 8.3%
Cerebral Haemorrhage 8.3%
Eye Haemorrhage 8.3%
Haematuria 8.3%
Haemorrhage Intracranial 8.3%
Hepatitis 8.3%
Inflammatory Bowel Disease 8.3%
Paraesthesia 8.3%
Pneumonia 8.3%
Thrombocytopenia 8.3%
Concomitant
Hypertension 43.3%
Diabetes Mellitus 14.7%
Type 2 Diabetes Mellitus 9.3%
Product Used For Unknown Indication 4.3%
Depression 4.0%
Cardiac Failure 3.9%
Hyperlipidaemia 3.6%
Drug Use For Unknown Indication 2.6%
Coronary Artery Disease 2.2%
Chronic Obstructive Pulmonary Disease 1.9%
Atrial Fibrillation 1.7%
Colorectal Cancer Metastatic 1.4%
Thrombosis Prophylaxis 1.1%
Blood Pressure 0.9%
Hyperuricaemia 0.9%
Insomnia 0.9%
Neuropathy Peripheral 0.9%
Angina Pectoris 0.8%
Device Therapy 0.8%
Essential Hypertension 0.8%
Cardiac Failure 10.6%
Hypertensive Crisis 7.4%
Blood Pressure Systolic Increased 6.4%
Cardiac Failure Congestive 6.4%
Cerebrovascular Accident 6.4%
Anaemia 5.3%
Atrial Fibrillation 5.3%
Blood Pressure Diastolic Decreased 5.3%
Renal Failure 5.3%
Angina Pectoris 4.3%
Blood Pressure Increased 4.3%
Death 4.3%
Dyspnoea 4.3%
Pain 4.3%
White Blood Cells Urine Positive 4.3%
Cataract 3.2%
Haemoptysis 3.2%
Hypotonia 3.2%
Melaena 3.2%
Stent Placement 3.2%

Drug Data